Bipolar Disorder

What is new in research on bipolar disorder?

Here’s a look back at selections from our March content series on mood disorders.

Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.

What is spring mania, and what are some effective clinical strategies for addressing it?

Take a look back at our recent coverage relating to our March content theme.

What is new in research on ADHD?

Write to us now to be part of our series focused on mood disorders this month.

From connections between bipolar disorder and cardiometabolic issues to management of agitation in emergency departments, here are highlights from the week in Psychiatric Times.

“Listen to your heart.” Researchers investigated the risks of cardiometabolic disease, heart failure, and mortality in bipolar disorder in a population-based cohort study.

What is new in research on bipolar disorder?

From the impact of BMI on clinical features of bipolar disorder to FDA approval of the first integrated TMS system for MDD and OCD, here are highlights from the week in Psychiatric Times.

“Weight” a minute! Researchers investigated the impact of body mass index on the clinical features of bipolar disorder in the STEP-BD study.

Here are some updates from the world of psychiatry throughout the month of January.

Examine a case of an adolescent with psychosis that seemed to develop during chemotherapy treatment.

What is new in research on posttraumatic stress disorder?

The data assess the extended efficacy of the treatment for up to 4 years.

OABD is a significant concern among older adults, characterized by unique presentations and comorbidities. Here's what you need to know.

What is new in research on ADHD?

What is new in research on bipolar disorder?

Here are some updates from the world of psychiatry throughout the month of October.

What are some key considerations in diagnosing bipolar disorder? Joseph F. Goldberg, MD, shares insights at the recent 2023 Annual Psychiatric Times World CME Conference.

This study is the first to assess the efficacy of this drug combination in a real-world setting.

Get ready for our upcoming virtual, interactive conference with some highlights from 2022.

From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.

An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.